The Korean Academy of Tuberculosis and Respiratory Diseases (KATRD) represents health professionals and scientific societies related to respiratory disease in South Korea. KATRD endeavors to promote research, patient care, and education in the field of respiratory disease and to improve the health of patients with respiratory diseases in South Korea. Founded in 1953, KATRD has the 66 years of history. Since 1962, the society has held more than 120 academic conferences and 1,656 membership.
Prenosis
Prenosis is a biology-based technology company redefining the standard of care for critical conditions. We believe healthcare should not follow a one-size-fits-all model. Instead, our mission is to tailor healthcare to each patient’s biology through the creation and delivery of integrated diagnostics and therapeutics. We use deep data and AI to build tools that augment clinical diagnosis of critical conditions based on each patient’s unique biological profile. Unlike other AI-driven diagnostics, we go further by developing therapies that help providers deliver personalized care. Our Immunix™ platform powers the development of a variety of AI-based diagnostics, including Sepsis ImmunoScore®, the first FDA-authorized AI diagnostic tool for sepsis. At Prenosis, we see people differently. For more information, visit us at prenosis.com or find us on LinkedIn.
Praxis Medical LLC
Praxis Medical is committed to developing innovative technologies that address unmet clinical needs to improve the lives of doctors, providers, and most importantly, patients. We are developing EndoCore- the world’s first motorized EBUS fine needle biopsy device. The EndoCore is designed to rotate the EBUS needle at the time of biopsy to harvest more cellular material in fewer passes. *This device is investigational.
PAREXEL
Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ | Parexel is among the world’s largest CROs, providing full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, we collaborate with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials for patients. We work With HeartTM every day to treat patients with dignity and learn from their experiences, so every trial makes a difference.